Submit Deal

SURVEYOR CAPITAL

HQ - Chicago

Summary

Surveyor Capital is a global, multi-manager equities strategy and is one of Citadel's three fundamental equities businesses.

Deals Overview

Total Deals52

Valued Deals51

Total Value£ 8.74 B

Avg. Deal Size£ 171 M

Market Context

Senior Management

Audrey DeBarros
Founder and CEO
Kenneth C. Griffin
Founder, CEO and Co-CIO
Todd Barker
CEO

Sort

28 Oct 2019|United States|Biotechnology

Target: NUVATION BIO INC

Bidder: BAUPOST GROUP

13 Service Providers

1 Target | 12 Bidder

13 Dealmakers

1 Target | 12 Bidder

£ 214 M

Value

30 Mar 2020|United States|Biotechnology

Target: ELEVATEBIO LLC

Bidder: THE INVUS GROUP LLC

12 Service Providers

3 Target | 9 Bidder

24 Dealmakers

9 Target | 15 Bidder

£ 137 M

Value

30 Jul 2020|United States|Pharmaceuticals

Target: CEREVEL THERAPEUTICS

Bidder: ECOR1 CAPITAL

27 Service Providers

7 Target | 20 Bidder

66 Dealmakers

20 Target | 46 Bidder

£ 1.00 B

Value

18 Aug 2020|Canada|Biotechnology

Target: CHINOOK THERAPEUTICS

Bidder: ECOR1 CAPITAL

18 Service Providers

5 Target | 13 Bidder

15 Dealmakers

2 Target | 13 Bidder

£ 80 M

Value

24 Aug 2020|United States|Pharmaceuticals

Target: KRONOS BIO

Bidder: PERCEPTIVE ADVISORS LLC

18 Service Providers

3 Target | 15 Bidder

18 Dealmakers

3 Target | 15 Bidder

£ 118 M

Value

26 Aug 2020|United States|Biotechnology

Target: KINNATE BIOPHARMA

Bidder: NEXTECH INVEST

9 Service Providers

1 Target | 8 Bidder

9 Dealmakers

1 Target | 8 Bidder

£ 74 M

Value

30 Mar 2020|United States|Pharmaceuticals

Target: ANNEXON

Bidder: ADAGE CAPITAL MANAGEMENT

15 Service Providers

3 Target | 12 Bidder

16 Dealmakers

4 Target | 12 Bidder

£ 81 M

Value

08 Jul 2020|United States|Biotechnology

Target: VELOSBIO INC

Bidder: CORMORANT ASSET MANAGEMENT

14 Service Providers

2 Target | 12 Bidder

16 Dealmakers

2 Target | 14 Bidder

£ 105 M

Value

15 Oct 2020|Switzerland|Biotechnology

Target: VECTIVBIO

Bidder: CORMORANT ASSET MANAGEMENT

16 Service Providers

3 Target | 13 Bidder

35 Dealmakers

16 Target | 21 Bidder

£ 84 M

Value

28 Oct 2020|United States|Biotechnology

Target: MIRAGEN THERAPEUTICS

Bidder: VENROCK

16 Service Providers

5 Target | 11 Bidder

19 Dealmakers

5 Target | 14 Bidder

£ 70 M

Value

05 Jan 2021|United States|Biotechnology

Target: IKENA ONCOLOGY

Bidder: OMEGA FUNDS

15 Service Providers

3 Target | 12 Bidder

15 Dealmakers

3 Target | 12 Bidder

£ 88 M

Value

26 Feb 2021|United States|Biotechnology

Target: ARTIVA BIOTHERAPEUTICS

Bidder: ACUTA CAPITAL

16 Service Providers

3 Target | 13 Bidder

16 Dealmakers

3 Target | 13 Bidder

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy